Dear Colleagues,

It gives me great pleasure to welcome you all to the 17th Annual Conference of the Saudi Association for Pulmonary Hypertension (SAPH2024) which will be held in Riyadh Marriott Hotel, KSA from 15-17 February 2024.

SAPH is maintaining the quest for development and progress year after year. SAPH2024 aims to create a platform for regional medical professionals to engage in exchange for knowledge and expertise on the latest and best practice methods in Pulmonary Hypertension.

As a continuation of successful collaboration between the Saudi Association for Pulmonary Hypertension (SAPH) and the Pulmonary Vascular Research Institute (PVRI), it has been proven that it is highly successful and helped in introducing physicians in The Middle East and North African countries to the world experts in the field of Pulmonary Hypertension and to the most advanced developments in understanding and managing Pulmonary Hypertension.

The scientific committee is planning a comprehensive Scientific Program covering all aspects of Pulmonary Vascular Diseases in both Adult & Children, from the basics of Pathobiology and Pathophysiology, Diagnosis, Classification and Management to the most advanced development in Therapies and Interventional Modalities. The program will be covered by the internationally recognized leaders in the field of Pulmonary Hypertension.

We are much appreciative to all our distinguished speakers and chairpersons. My hope is that all those who are practicing physicians will make an effort to attend and benefit from this Conference.

With my best regards,

Prof. Abdullah M. Aldalaan, MD
President, Saudi Association for Pulmonary Hypertension (SAPH)
Consultant, Pulmonary Medicine
Director, Pulmonary Hypertension Program, Lung Health Center
King Faisal Specialist Hospital and Research Centre
Professor of Medicine, Alfaisal University
Riyadh, Saudi Arabia